A 32-year-old man who had had frequent gouty arthritis over the past 17 years, was admitted for acute renal failure. Acute renal failure was improvedrapidly after medication was resumed and the patient was sufficiently hydrated. The hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity in the patient had been reduced to about 30%of the normal control. Therefore we considered that this patient suffered from a partial deficiency ofHPRT.A point mutation ofHPRT gene 68G (guanine) to T (thymine) was detected. This is a mutation that has not been previously reported. Familial analysis indicated that his mother and sister were heterozygotes. (Internal Medicine 37: 945-949, 1998) 
Introduction
Hypoxanthine-guanine phosphoribosyltransferase (HPRT)
is a salvage enzyme in the purine nucleotide metabolism (1) .
HPRTdeficiency is an X-linked recessive disease. Complete deficiency of this enzyme is knownas Lesch-Nyhansyndrome which is characterized by mental retardation, self-mutilation, choreoathetosis, hyperuricemia, gout, renal damage and urolithiasis. These symptoms generally become apparent several months after birth. In contrast, most patients with partial deficiency of this enzymedo not suffer from mental retardation or self-mutilation (2) (3) (4) (5) (6) . This report describes a clinical course and gene analysis of a patient with a partial deficiency ofHPRT who was originally examined for gouty arthritis and acute renal failure.
For editorial comment, see p 905.
Case Report
The patient, a 32-year-old man, has suffered from gout since the age of 15 and has taken allopurinol at a dosage of200 to 300 mg a day since he was 17 years old. Due to lazy taking medication, he sometimes had urolithiasis and acute gouty arthritis of the metatarsal-phalangealjoints of the first toe. None of his family membershave suffered from gout or hyperuricemia. Consanguineousmarriages have never occured in his family. Whenhe was 30 years old, he was admitted to a hospital because of acute renal failure. A sufficient hydration rapidly improved the renal failure and reduced the concentration of serumuric acid. A treatment of 25 mg of benzbromarone and 200 mg of allopurinol had been started one monthbefore admission to our hospital. Having noticed a swelling of the left wrist joint and gross hematuria and having severe hyperuricemia (serum uric acid, 20.4 mg/dl) and renal insufficiency (serum creatinine, 1.5 mg/dl), he was admitted to our hospital for further examination. He showedno evidence of abnormality in mental and intellectual development nor in physical development. Both sides of the wrist joints, some of the finger joints, and the metatarsalphalangeal joints of the first toe were deformed. Results from the Fishberg concentration test suggested the presence of renal medullary damage (Table 1) . Renal calculi were detected with ultrasonography ( Fig. 1 ) and computed tomography of the abdomen. These calculi had formed distinct nodules in the renal medulla. These findings were compatible with renal calculi caused by hyperuricemia (7).
In order to examine his purine metabolism, the medication was interrupted after admission. The serum uric acid level rose to 1 8.8 mg/dl and urinary excretion of uric acid (UuaV) amounted to 1,910 mg a day after the interruption ( Fig. 2) . His creatinine and uric acid clearance simultaneously came down to 34.3 and 2.0 ml/minute, respectively. After the resumption of allopurinol at a dosage of 200 mga day, the serum uric acid level, urinary excretion of uric acid, and creatinine clearance were rapidly improved. These results clearly suggested that this patient suffered from gout due to an overproduction of uric acid. This strongly showed the presence of abnormal purine metabolism.
Analysis of purine nucleotide metabolism and enzyme kinetics The serum concentrations of hypoxanthine and xanthine of the patient were measured by the HPLC method (8, 9 HPRT, the adenine phosphoribosyltransferase (APRT), purine nucleotide phosphorylase (PNP) and adenosine deaminase (ADA) activity in the erythrocytes of the patient were measured as previously reported (8, 9). The erythrocytes of a healthy female were used as a normalcontrol for enzymeactivity measurements.Theserum concentrations of hypoxanthineand xanthine were markedly increased ( Table 2 ). The HPRTactivity in the patient was 0.70 IU/gHb, about one-third of the control (2.30 IU/gHb). The APRT activity in the patient was 0.61 IU/ gHb, twice that of the control. The PNP and ADAactivities in the patient were normal. Fromthese results, weconcluded that the patient suffered from a partial deficiency of HPRT. The Kmof the HPRTfor 5'-phosphoribosyl 1-pyrophosphate in the patient was increased at 160 |imol// compared to that of normal HPRT(90-130 jamol// in the control). The Km for hypoxanthine (20 jiimol//) was in the normal range (1 8-22 jamol//).
Gene analysis
Total RNAswere isolated from the lymphocytes and RT-PCR was performed. The 693 bp CDNAwhich contained coding region of HPRTwere amplified using the primers as previously reported (10). The obtained HPRTcDNAswere cloned with a sequencing vector (PCR Script SK(+) STRATAGENE, La Jolla, California, USA). The CDNA sequencing procedure was performed for the 3 clones by an autosequencer. A point mutation was recognized on the CDNA, 68G (guanine) to T (thymine), which substituted cystine for phenylalanine in codon 23. This mutation was also confirmed inthe exon 2 ofgenomic DNA (Fig. 3) . This is amutation which has not been previously reported.
Familial analysis Weexamined his mother and younger sister. His mother was 61 years old, and her serum uric acid level was 6.4 mg/dl. His younger sister was 23-year-old, and her serum uric acid level was 4.9 mg/dl.
A nested PCRwas performed for his mother and younger
Internal Medicine Vol. 37, No. 1 1 (November 1998) sister (Fig. 4) . The first PCRwas performed using primers a and b. The product was 527bp which contained exon 2. The second PCRwas carried out using primers c and d. The portion amplified by primer c and d did not contain the digestible site for any digestive enzyme. The primer d is designed so that the PCR product from the normal HPRTgene is recognized by Sphl, while the product from the mutant HPRTgene is not recognized by Sphl. By digestion of Sphl, the product from normal individuals is digested into 86bp and 16bp bands while the product from mutants remains in the 102bp bands. The results of electrophoresis showed that his mother and younger sister had both 86bp and 102bp bands. This result indicated that they were heterozygotes.
Discussion
Weexamined a patient who had frequent attacks of gout and an episode of acute renal failure. Fromthe results of some examinations, weconsidered that this patient suffered from a partial deficiency of HPRT. It has been described that patients with HPRTdeficiency suffer from uric acid nephropathy and urolithiasis (1 1 , 12) . The increased serum and urinary concentrations of uric acid led to the deposit of uric acid in the renal tubules (7, 12). Further, Emmersonand Rowdescribed that the microtophi cause insufficiency of nephron function (12). The nephropathy in patients with HPRTpartial deficiency is seen mainly in the medulla, and the incidence of acute renal failure is low ( 13, 14).
The characteristic clinical courses of acute renal failure in patients with HPRTdeficiency are reported to be uric acid nephropathy and the deterioration of renal function which is reversible by an intensive alkaline diuresis, hydration, or ad- Figure 4 . Family study. The first PCR was performed using primers a and b. The product was 527bp which contained exon 2. The second PCRwas carried out using primers c and d. The primer d is designed so that the PCR product (102bp) from only normal HPRT gene is able to be recognized by Sphl. The results ofelectrophoresis showedthat his mother and younger sister had two bands. They are considered as heterozygotes.
948
Internal Medicine Vol. 37, No. 1 1 (November 1998) ministration of allopurinol (12) (13) (14) . In the present case, acute renal failure was also ameliorated by hydration, alkalization, and administration of allopurinol. In previous reports, the concentration of serum uric acid in patients with HPRTpartial deficiency ranged from 7 to as high as 18 mg/dl (15) (16) (17) . In patients with partial deficiency of HPRTand renal insufficiency as in the present case, the concentration of serum uric acid is sometimes over 20 mg/dl (12-14). In our case, the concentration of serumuric acid rose to 20.4 mg/ dl before admission and to 18.8 mg/dl after the cessation of allopurinol. This is consistent with previous cases. The maximumUuaVin the patient was 34.7 mg/kg/day. This result is also similar to previous cases with HPRTpartial deficiency which were reported as 10 to 36 mg/kg/day (18). Serum concentrations of hypoxanthine and xanthine in the present case were extremely elevated in contrast with those of previously reported cases (13). The reason was presumed as follows: In the duration from blood sampling to separation of the serum, the erythrocytes were disrupted, and xanthine and hypoxanthine in the erythrocytes might have leaked into the serum.
The activity of HPRTwas decreased to about 30%of control, while activity of APRTwas increased to two-fold normal. The activity of HPRTin partial deficient patients is reported as 0.01% to 70% (12). The activity ofAPRT generally increased two-to three-fold normal (18-20). Rubin et al reported that the APRTactivity in the circulating erythrocytes of Lesch-Nyhan syndrome is more stable than that of normal subjects (19). Some investigators have suggested that the protection of the APRTstability from thermal inactivation is due to increased PRPP(20). However, the mechanism has not becomecompletely clear.
In a molecular biological analysis of this case, the change in the nucleotide 68G to T of HPRTgene was recognized. This is a mutation that has not been previously reported. This mutation substituted amino acid 23 Cysteine to Phenylalanine. A change of amino acid 23 was reported by Sege-Peterson et al, as nucleotide 69C to G and amino acid Cysteine to Tryptophan (21) . In their report, the enzymeactivity ofHPRTwas reduced to about 30% of that of a normal individual, which generally corresponds to the present case. Keough et al reported that the region that includes 23 Cysteine is a binding site for PRPP (22) . Ananomalyin this region wouldalter the structure of the protein, reducing the affinity of PRPP. It might be difficult to identify patients with HPRTpartial deficiency. However, they sometimes develop acute renal failure and it is considered to be reversible in the early stages. The clinical course of the present case tells us the importance of the management of urinary flow in such patients. The patient should be fully instructed to take his medication regularly and to pay particular attention to avoiding dehydration.
